In nasopharyngeal carcinoma, decreased ANXA1 leads to the upregulation of S100A9/vimentin, which increases tumour invasion by regulating the function of the cytoskeletal proteins (Xiao et al., 2017). The gene discussed is ANXA1; the disease is nasopharyngeal carcinoma.